Last 35,800 KRW
Change Today +700.00 / 1.99%
Volume 14.7K
086450 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 1:29 AM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

dongkook pharmaceutical co l (086450) Snapshot

Open
35,150
Previous Close
35,100
Day High
36,000
Day Low
34,500
52 Week High
10/21/14 - 47,000
52 Week Low
06/13/14 - 24,500
Market Cap
318.3B
Average Volume 10 Days
20.1K
EPS TTM
2,113
Shares Outstanding
8.9M
EX-Date
12/27/13
P/E TM
16.9x
Dividend
280.00
Dividend Yield
0.78%
Current Stock Chart for DONGKOOK PHARMACEUTICAL CO L (086450)

Related News

No related news articles were found.

dongkook pharmaceutical co l (086450) Related Businessweek News

No Related Businessweek News Found

dongkook pharmaceutical co l (086450) Details

DONGKOOK Pharmaceutical Co., Ltd. offers pharmaceutical products in South Korea. Its products include Sodium Hyaluronate injection for defornative osteoarthritis of the knees and periathritis of the shoulder; Gadopentetate Dimeglumine injection for contrasr enhancement during cranial and spinal MRI investigations; Octrin LAR injection for acromegaly, carcinoidtumors, and vasoactive intestinal peptide tumors; and Iopamidol injection for use as an X-ray contrast media for neuroradiology, angiography, urography, and computer tomography. The company’s products also comprise Triptorelin Depot injection for prostatic carcinoma, the management of advanced prostatic carcinoma, and fenital and extragenital endometriosis; Pofol injection, an intravenous anesthetic for induction and maintenance of general anesthesia and sedation of ventilated patients receiving intensive care; and Teicoplanin injection for skin and soft tissue infections, urinary and lower respiratory tract infections, joint and bone infections, septicaemia, endocarditis, and peritonitis related to continuous ambulatory peritoneal dialysis. In addition, it offers Streptokinase injection for the therapeutic indication of acute myocardial infarction, acute massive pulmonary embolism, acute deep vein thrombosis, acute arterial thrombosis and embolism, and occluded arteriovenous cannulae; Leuprorelin acetate injection for the treatment of prostatic cancer, endometriosis, premenopausal breast cancer, and central precocious puberty, as well as reduction of myoma nucleus and improvement of symptom in uterine myoma; and Alprostadil injection for chronic arteriosclerosis and skin ulcers. Further, the company provides raw material medicines. It also exports its products. The company was formerly known as UEC & Co., Ltd. DONGKOOK Pharmaceutical Co., Ltd. was founded in 1968 and is based in Seoul, South Korea.

Founded in 1968

dongkook pharmaceutical co l (086450) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

dongkook pharmaceutical co l (086450) Key Developments

Probi Announces Distribution Agreement with Dongkook Pharmaceutical

Probi has signed a distribution agreement with Dongkook Pharmaceutical Co., Ltd. for the distribution of Probi's gut health product, Probi Mage®. The Product will be launched under Probi's brand in South Korea in the second quarter of 2014. Dongkook will launch Probi Mage® as a dietary supplement in department stores and TV/Internet home shopping.

DONGKOOK Pharmaceutical Co., Ltd., Annual General Meeting, Mar 15, 2013

DONGKOOK Pharmaceutical Co., Ltd., Annual General Meeting, Mar 15, 2013., at 10:00 Korea Standard Time. Location: Dongguk building basement floor auditorium. Agenda: To consider approval of financial statements; to consider incorporation of some changes; to consider election of directors; to consider approval of directors' remuneration limit; to consider approval of the audit fees limit; and to consider other references concerning investment decisions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
086450:KS 35,800.00 KRW +700.00

086450 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 086450.
View Industry Companies
 

Industry Analysis

086450

Industry Average

Valuation 086450 Industry Range
Price/Earnings 15.6x
Price/Sales 1.3x
Price/Book 1.7x
Price/Cash Flow 15.1x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DONGKOOK PHARMACEUTICAL CO L, please visit www.dkpharm.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.